1: Camacho A, Segoviano-Ramírez JC, Sánchez-Garcia A, de Jesus Herrera-de la Rosa J, García-Juarez J, Hernandez-Puente CA, Calvo-Anguiano G, Maltos-Uro SR, Olguin A, Gojon-Romanillos G, Gojon-Zorrilla G, Ortiz-Lopez R. Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro. Lipids Health Dis. 2018 May 29;17(1):128. doi: 10.1186/s12944-018-0784-7. PMID: 29843731; PMCID: PMC5975476.
2: Liang BC, Ullyatt E. Chemosensitization of glioblastoma cells to bis- dichloroethyl-nitrosourea with tyrphostin AG17. Clin Cancer Res. 1998 Mar;4(3):773-81. PMID: 9533547.
3: Hori H, Nagasawa H, Uto Y, Ohkura K, Kirk KL, Uehara Y, Shimamura M. Design of hypoxia-targeting protein tyrosine kinase inhibitor using an innovative pharmacophore 2-methylene-4-cyclopentene-1,3-dione. Biochim Biophys Acta. 2004 Mar 11;1697(1-2):29-38. doi: 10.1016/j.bbapap.2003.11.011. PMID: 15023348.
4: Holtick U, Vockerodt M, Pinkert D, Schoof N, Stürzenhofecker B, Kussebi N, Lauber K, Wesselborg S, Löffler D, Horn F, Trümper L, Kube D. STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis. Leukemia. 2005 Jun;19(6):936-44. doi: 10.1038/sj.leu.2403750. PMID: 15912144.
5: Burger AM, Kaur G, Alley MC, Supko JG, Malspeis L, Grever MR, Sausville EA. Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondria. Cancer Res. 1995 Jul 1;55(13):2794-9. Erratum in: Cancer Res 1995 Aug 15;55(16):3684. PMID: 7796405.
6: Sausville EA. Correspondence re: G. Palumbo et al., the tyrphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2. Cancer Res., 57: 2434-2439, 1997. Cancer Res. 1997 Dec 15;57(24):5610. PMID: 9407975.
7: Palumbo GA, Yarom N, Gazit A, Sandalon Z, Baniyash M, Kleinberger-Doron N, Levitzki A, Ben-Yehuda D. The tryphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2. Cancer Res. 1997 Jun 15;57(12):2434-9. PMID: 9192822.
8: Ohkura K, Hori H. Modification of cell response to insulin by membrane-acting agents in rat white adipocytes: analysis of structural features by computational simulation. Bioorg Med Chem. 2001 Nov;9(11):3023-33. doi: 10.1016/s0968-0896(01)00199-7. PMID: 11597485.
9: Yura Y, Kusaka J, Tsujimoto H, Yoshioka Y, Yoshida H, Sato M. Effects of protein tyrosine kinase inhibitors on the replication of herpes simplex virus and the phosphorylation of viral proteins. Intervirology. 1997;40(1):7-14. doi: 10.1159/000150515. PMID: 9268765.
10: Hori H, Nagasawa H, Ishibashi M, Uto Y, Hirata A, Saijo K, Ohkura K, Kirk KL, Uehara Y. TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity. Bioorg Med Chem. 2002 Oct;10(10):3257-65. doi: 10.1016/s0968-0896(02)00160-8. PMID: 12150871.
11: Ghorab MM, Ragab FA, Heiba HI, Elsayed MSA, Ghorab WM. Design, synthesis and molecular modeling study of certain 4-Methylbenzenesulfonamides with CDK2 inhibitory activity as anticancer and radio-sensitizing agents. Bioorg Chem. 2018 Oct;80:276-287. doi: 10.1016/j.bioorg.2018.06.010. Epub 2018 Jun 5. PMID: 29966874.
12: Ohkura K, Kawaguchi Y, Tatematsu Y, Uto Y, Hori H. An Antitumor 2-Hydroxyarylidene-4-cyclopentene-1,3-Dione as a Protein Tyrosine Kinase Inhibitor: Interaction Between TX-1123 Derivatives and Src Kinase. Anticancer Res. 2016 Jul;36(7):3645-9. PMID: 27354635.
13: Lama Z, Gaudin Y, Blondel D, Lagaudrière-Gesbert C. Kinase inhibitors tyrphostin 9 and rottlerin block early steps of rabies virus cycle. Antiviral Res. 2019 Aug;168:51-60. doi: 10.1016/j.antiviral.2019.04.014. Epub 2019 May 7. PMID: 31071352.
14: Gillespie J, Dye JF, Schachter M, Guillou PJ. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors. Br J Cancer. 1993 Dec;68(6):1122-6. doi: 10.1038/bjc.1993.491. Erratum in: Br J Cancer 1994 Oct;70(4):780. PMID: 8260363; PMCID: PMC1968666.
15: Yura Y, Kusaka J, Kondo Y, Tsujimoto H, Yoshida H, Sato M. Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1. Arch Virol. 1995;140(7):1181-94. doi: 10.1007/BF01322745. PMID: 7544112.
16: Lander HM, Levine DM, Novogrodsky A. Agonistic effects of tyrphostins on human peripheral mononuclear cells. Cell Immunol. 1992 Oct 1;144(1):155-68. doi: 10.1016/0008-8749(92)90233-f. PMID: 1394436.
17: Starkov AA. "Mild" uncoupling of mitochondria. Biosci Rep. 1997 Jun;17(3):273-9. doi: 10.1023/a:1027380527769. PMID: 9337482.
18: Terada H. Uncouplers of oxidative phosphorylation. Environ Health Perspect. 1990 Jul;87:213-8. doi: 10.1289/ehp.9087213. PMID: 2176586; PMCID: PMC1567840.
19: Tatematsu Y, Hayashi H, Taguchi R, Fujita H, Yamamoto A, Ohkura K. Effect of N-Phenylanthranilic Acid Scaffold Nonsteroidal Anti-inflammatory Drugs on the Mitochondrial Permeability Transition. Biol Pharm Bull. 2016;39(2):278-84. doi: 10.1248/bpb.b15-00717. PMID: 26830486.
20: Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H. Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety. Bioorg Med Chem. 2008 Jun 1;16(11):6042-53. doi: 10.1016/j.bmc.2008.04.041. Epub 2008 Apr 24. PMID: 18474428; PMCID: PMC3113482.